Schedule 13G ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2019-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-19-001000
Form type
SC 13G/A
Filer
Cormorant Asset Management, LP
CIK
CIK 1583977
Filed
Nov 14, 2019
Reporting period
Nov 04, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub